-
1
The gut microbiome affects drug absorption and metabolism.
-
2
Specific gut bacteria can inactivate drugs like digoxin.
-
3
Standardized microbiome testing is lacking.
-
4
Next-gen sequencing helps map the microbiome.
-
5
The FDA approved microbiome-based therapies.
-
6
Personalized medicine can improve drug efficacy.
-
7
Machine learning aids in identifying beneficial microbial strains.
-
8
Microbiome insights can tailor therapies to individual patients.
Original Source(s)
Related Content
FDA Reshapes Drug Testing Approach
The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.
April 20, 2026
-
2 min
The Tenure Clock Doesn’t Pause for Politics
Academic institutions need a structured response to federal research defunding
by Kerri Miller
April 20, 2026
-
2 min
ACP Updates Breast Cancer Screening Guidance
Biennial mammography recommended for ages 50 to 74 years, with shared decision-making outside that range.
by Kerri Miller
April 17, 2026
-
6 min
